Clinical Trial Update: Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing intraoperative TAP block with bupivacaine/dexamethasone to liposomal bupivacaine (Exparel) for postoperative pain; study completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Crohn Disease
• Digestive System Disease
• Gastrointestinal Cancer
• Gastrointestinal Disease
• Inflammatory Bowel Diseases
• Intestinal Disease
• Pain
• Pain Neuropathic
• Pain Postoperative

Drugs mentioned

• Bupivacaine (Bupivacaine)
• Exparel (liposomal bupivacaine)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Pain, Postoperative, Crohn Disease | Phase 4 | Status: COMPLETED | Results posted: 2021-02-17